Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02332096 · ClinicalTrials.gov registry record
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
A clinical trial of Atrial Fibrillation and Obstructive Sleep Apnea, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT02332096: Completed study of Atrial Fibrillation and Obstructive Sleep Apnea, sponsored by Beth Israel Deaconess Medical Center.
NCT02332096 is a study of Atrial Fibrillation and Obstructive Sleep Apnea that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 130 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02332096, a study of Atrial Fibrillation and Obstructive Sleep Apnea, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Diagnosis and treatment of sleep apnea with continuous positive airway pressure (CPAP) therapy has been shown to decrease arrhythmia recurrence in patients with AF following ablation. However, patients with AF undergoing ablation are not routinely screened for sleep apnea, despite an estimated sleep apnea prevalence of 25% in the general population, and perhaps higher among patients with AF. Home sleep testing is frequently used for evaluation of sleep apnea.
Conditions Studied
Interventions
- DEVICE Home Sleep Testing Device
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-02-07 |
What the finished NCT02332096 record still lists
NCT02332096 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Home Sleep Testing Device is the first listed.
NCT02332096 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02332096 about?
NCT02332096 is a clinical study titled "Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation". Diagnosis and treatment of sleep apnea with continuous positive airway pressure (CPAP) therapy has been shown to decrease arrhythmia recurrence in patients with AF following ablation. However, patients with AF undergoing ablation are not routinely screened for sleep apnea, despite an estimated sleep...
What is the current status of trial NCT02332096?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2015-06. Estimated completion is 2020-02-07.
What conditions does trial NCT02332096 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Obstructive Sleep Apnea, Cardiac Arrhythmias.
What interventions are being tested in trial NCT02332096?
The interventions under investigation include: Home Sleep Testing Device (DEVICE).
Who is sponsoring clinical trial NCT02332096?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02332096 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02332096's enrollment target sits among peer trials
130 128th of 202 higher than 74 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia